Sun Pharma Quarterly Result: Rs 1444 crore PAT in Q1FY22; stock ends over 10%
The pharmaceutical major — Sun Pharma on Friday reported in-line first-quarter results, as expected by the majority of the brokerages, it posted a net profit of Rs 1,444.17 crore for the June-ended quarter of the financial year 2021-22, as compared to a net loss of Rs 1,655.6 crore in the same period last year.
Amid in-line Q1 numbers, the shares of Sun Pharma spurted 11 per cent intraday: PTI